Researchers found that the medications "are significantly more effective than metformin in reducing BMI, waist circumference, and insulin resistance in patients with PMOS." "However, they are more likely to be associated with some adverse reactions as headache and nausea." For women who have PMOS and who take GLP-1s, Dr
However, persistent or worsening fatigue beyond the initial adaptation period warrants clinical evaluation
This applies to adolescents and should be discussed with the patient and documented
Immediately discontinue use if irritation or rash occurs
The assessment part will include a detailed analysis of each drug, drug class, clinical studies, phase type, drug type, route of administration, and ongoing product development activities related to GLP-1 agonists
Call us and schedule your appointment today!